Cardiolipin Synthase (CLS) (Middle Region) Peptide
Quick Overview for Cardiolipin Synthase (CLS) (Middle Region) Peptide (ABIN975322)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- WTIPNMLSMT RIGLAPVLGY LIIEEDFNIA LGVFALAGLT DLLDGFIARN
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CRLS1 Antibody(ARP49444_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CRLS1 (CLS) (Cardiolipin Synthase (CLS))
-
Background
-
CRLS1 catalyzes the reversible phosphatidyl group transfer from one phosphatidylglycerol molecule to another to form cardiolipin (CL) (diphosphatidylglycerol) and glycerol.
Alias Symbols: C20orf155, CLS1, GCD10, dJ967N21.6, CLS
Protein Interaction Partner: MCM6,MCM7
Protein Size: 301 -
Molecular Weight
- 32 kDa
-
Gene ID
- 54675
-
NCBI Accession
- NM_019095, NP_061968
-
UniProt
- Q9UJA2
Target
-